We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: ADHD Meds Not Linked to Higher Risk of Serious Heart Events
FDA: ADHD Meds Not Linked to Higher Risk of Serious Heart Events
December 16, 2011
The FDA will not change its recommendations for use of attention deficit hyperactivity disorder (ADHD) drugs, the agency said Dec. 12, offering data from two studies that found the drugs did not increase the risk of serious adverse cardiovascular events in adults.